NovaBridge Biosciences (FRA:0VY)
Germany flag Germany · Delayed Price · Currency is EUR
1.630
+0.020 (1.24%)
At close: Aug 26, 2026

NovaBridge Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-117.55-88.34-22.23-207.73-371.05-367.02
Depreciation & Amortization
1.030.860.981.061.424.84
Other Amortization
3.8---2.250.12
Loss (Gain) From Sale of Assets
0.030.02-0.01--0.030.05
Asset Writedown & Restructuring Costs
42.0742.071.2523.04--
Loss (Gain) From Sale of Investments
1.421.75--0.22-1.9-4.78
Loss (Gain) on Equity Investments
--1.0411.464.7157.91
Stock-Based Compensation
12.25.97-1.9510.2413.1595.8
Other Operating Activities
-0.17--28.93126.63224.78-2.21
Change in Accounts Receivable
----1.5511.18
Change in Inventory
------4.29
Change in Unearned Revenue
-----34.08
Change in Other Net Operating Assets
11.4917.07-2.81-37.1215.5521.13
Operating Cash Flow
-45.68-20.6-106.63-146.5-90.22-153.18
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.99-0.01-0.05-0.16-2.09-4.71
Sale of Property, Plant & Equipment
-0.050.06---
Investment in Securities
13.23104.93-136.03-15-3.09-109.76
Investing Cash Flow
12.24104.97-136.02-15.16-5.18-114.47

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
62.6661.91-0.416.92115.31
Repurchase of Common Stock
---0.34-8.64-3.01-
Other Financing Activities
-4.19-4.19----21.82
Financing Cash Flow
58.4757.73-0.34-8.243.9193.49

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.210.280.575.214.2-20.27
Net Cash Flow
25.23142.37-242.4-164.7-77.3-194.43

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-46.67-20.6-106.68-146.66-92.32-157.89
Free Cash Flow Growth
------
Free Cash Flow Margin
----23206.33%--1139.46%
Free Cash Flow Per Share
-0.41-0.21-1.31-1.76-1.12-2.08
Levered Free Cash Flow
-47.59-37.11-68.15-58.8447.43-96.12
Unlevered Free Cash Flow
-47.59-37.11-68.15-58.8447.43-96.12

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
----0.1-
Cash Income Tax Paid
-----1.43
Change in Working Capital
11.4917.07-2.81-37.1217.0962.1